Corneal Nerve Pathway Function in Individuals with Dry Eye Symptoms.
Corneal Nerve Pathway Function in Individuals with Dry Eye Symptoms.
复制标题
DOI:
10.1016/j.ophtha.2020.07.061
复制
发表时间:
2021-04
期刊:
影响因子:
13.7
通讯作者:
Sarantopoulos CD
中科院分区:
文献类型:
--
作者:
Galor A;Felix ER;Feuer W;Levitt RC;Sarantopoulos CD
Dry eye (DE) disease is a multifactorial, chronic condition with a prevalence of 5-41 30%. 1 DE symptoms are a frequent presenting complaint to eye clinics and can include 42 sensations of dryness, as well as ocular pain (described as burning, aching, and 43 irritation) and vision-related disturbances. DE symptoms impact quality of life as they 44 reduce the ability to work and carry out activities of daily living. 1 Interestingly, DE 45 symptoms are often disparate from DE signs, which include decreased tear production, 46 increased tear evaporation, and inflammation, among others. One explanation for the 47 disparity is the variable contribution of corneal nerves, which are responsible for touch, 48 pain, and thermal sensation in the eye, to the pathophysiology of disease. In fact, the 49 updated definition for DE includes neurosensory dysfunction as a contributing facet, in 50 addition to tear and ocular surface abnormalities. 2 However, it is not known how many 51 individuals with DE symptoms have nerve abnormalities as a contributing feature of 52 disease. To address this knowledge gap, this research aimed to characterize corneal 53 nerve pathway function in individuals with DE symptoms and examine relationships 54 between metrics of nerve function and DE parameters. 55 This prospective cross-sectional study recruited veterans with DE symptoms (DE 56 Questionnaire (DEQ)-5≥ 6) from the Miami Veterans Administration (VA) eye clinic 57 between October 2013 and October 2017. The study was approved by the Miami VA 58 Institutional Review Board, adhered to the Declaration of Helsinki, and all individuals 59 provided written informed consent. To improve population homogeneity, we excluded 60 individuals with anatomic abnormalities (eg pterygium, corneal scar), systemic immune 61 diseases (eg Sjögrens, graft versus host disease), contact lens wear, and/or a history 62 of cornea, glaucoma, or retinal surgery. A history of cataract surgery> 6 months ago 63 was allowed. In addition, as topical medications can affect nerve function, we excluded 64 individuals using topical medications beyond artificial tears. 65 All individuals answered questionnaires regarding DE symptoms, including the 66 DEQ-5 and Ocular Surface Disease Index (OSDI), and underwent an ocular surface 67 examination, including: Inflammadry (Quidel), tear break up time (TBUT), corneal 68 staining graded to the National Eye Institute scale3, Schirmer score after topical 69 anesthesia, and meibum quality graded to the Bron scale. 3 Data from the more severely 70 affected eye was used for analysis. 71We characterized nerve function by examining a) corneal mechanical detection 72 threshold to air puff (in the right eye) 4 and b) the presence of persistent ocular pain after 73 placement of topical anesthesia (ie, a rating of at least 1 on a 0-10 pain intensity rating 74 scale recorded at 30 seconds after topical anesthesia). Aesthesiometry evaluates the 75 sensitivity of the entire sensory pathway from the cornea to the cerebral cortex while 76 response to topical anesthetic allows for assessment of the contribution of peripheral 77 nerve activity (indicated by elimination of pain after topical anesthetic) versus higher-78 order nociceptive nerve activity (persistence of pain after topical anesthetic). 79 All analyses were conducted with SPSS 26.0. T-tests, analysis of variance 80 (ANOVA), and chi-square analyses were used to compare means and frequencies. P-81 values< 0.05 were considered significant. 82 The mean age of the 403 individuals was 61 years±10. 90% of subjects were 83 male, 44% self-identified as white and 27% as Hispanic. DE symptoms were in the 84 severe …
影响因子:
2.4
作者:
Belmonte, Carlos
通讯作者:
Belmonte, Carlos
DOI:
10.1016/j.jtos.2017.05.002
发表时间:
2017-07
期刊:
The ocular surface
影响因子:
--
作者:
Belmonte C;Nichols JJ;Cox SM;Brock JA;Begley CG;Bereiter DA;Dartt DA;Galor A;Hamrah P;Ivanusic JJ;Jacobs DS;McNamara NA;Rosenblatt MI;Stapleton F;Wolffsohn JS
通讯作者:
Wolffsohn JS
影响因子:
4.4
作者:
Spierer, Oriel;Felix, Elizabeth R.;Galor, Anat
通讯作者:
Galor, Anat